Cargando…
Manubrium-limited ministernotomy versus conventional sternotomy for aortic valve replacement (MAVRIC): study protocol for a randomised controlled trial
BACKGROUND: Aortic valve replacement is one of the most common cardiac surgical procedures performed worldwide. Conventional aortic valve replacement surgery is performed via a median sternotomy; the sternum is divided completely from the sternal notch to the xiphisternum. Minimally invasive aortic...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5273792/ https://www.ncbi.nlm.nih.gov/pubmed/28129780 http://dx.doi.org/10.1186/s13063-016-1768-4 |
_version_ | 1782501782277062656 |
---|---|
author | Akowuah, Enoch Goodwin, Andrew T. Owens, W. Andrew Hancock, Helen C. Maier, Rebecca Kasim, Adetayo Mellor, Adrian Khan, Khalid Murphy, Gavin Mason, James |
author_facet | Akowuah, Enoch Goodwin, Andrew T. Owens, W. Andrew Hancock, Helen C. Maier, Rebecca Kasim, Adetayo Mellor, Adrian Khan, Khalid Murphy, Gavin Mason, James |
author_sort | Akowuah, Enoch |
collection | PubMed |
description | BACKGROUND: Aortic valve replacement is one of the most common cardiac surgical procedures performed worldwide. Conventional aortic valve replacement surgery is performed via a median sternotomy; the sternum is divided completely from the sternal notch to the xiphisternum. Minimally invasive aortic valve replacement, using a new technique called manubrium-limited ministernotomy, divides only the manubrium from the sternal notch to 1 cm below the manubrio-sternal junction. More than one third of patients undergoing conventional sternotomy develop clinically significant bleeding requiring post-operative red blood cell transfusion. Case series data suggest a potentially clinically significant difference in red blood cell transfusion requirements between the two techniques. Given the implications for National Health Service resources and patient outcomes, a definitive trial is needed. METHODS/DESIGN: This is a single-centre, single-blind, randomised controlled trial comparing aortic valve replacement surgery using manubrium-limited ministernotomy (intervention) and conventional median sternotomy (usual care). Two hundred and seventy patients will be randomised in a 1:1 ratio between the intervention and control arms, stratified by baseline logistic EuroSCORE and haemoglobin value. Patients will be followed for 12 weeks from discharge following their index operation. The primary outcome is the proportion of patients who receive a red blood cell transfusion post-operatively within 7 days of surgery. Secondary outcomes include red blood cell and blood product transfusions, blood loss, re-operation rates, sternal wound pain, quality of life, markers of inflammatory response, hospital discharge, health care utilisation, cost and cost effectiveness and adverse events. DISCUSSION: This is the first trial to examine aortic valve replacement via manubrium-limited ministernotomy versus conventional sternotomy when comparing red blood cell transfusion rates following surgery. Surgical trials present significant challenges; strengths of this trial include a rigorous research design, standardised surgery performed by experienced consultant cardiothoracic surgeons, an agreed anaesthetic regimen, patient blinding and consultant-led patient recruitment. The MAVRIC trial will demonstrate that complex surgical trials can be delivered to exemplary standards and provide the community with the knowledge required to inform future care for patients requiring aortic valve replacement surgery. TRIAL REGISTRATION: International Standard Randomised Controlled Trial Number (ISRCTN) ISRCTN29567910. Registered on 3 February 2014. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s13063-016-1768-4) contains supplementary material, which is available to authorized users. |
format | Online Article Text |
id | pubmed-5273792 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2017 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-52737922017-02-01 Manubrium-limited ministernotomy versus conventional sternotomy for aortic valve replacement (MAVRIC): study protocol for a randomised controlled trial Akowuah, Enoch Goodwin, Andrew T. Owens, W. Andrew Hancock, Helen C. Maier, Rebecca Kasim, Adetayo Mellor, Adrian Khan, Khalid Murphy, Gavin Mason, James Trials Study Protocol BACKGROUND: Aortic valve replacement is one of the most common cardiac surgical procedures performed worldwide. Conventional aortic valve replacement surgery is performed via a median sternotomy; the sternum is divided completely from the sternal notch to the xiphisternum. Minimally invasive aortic valve replacement, using a new technique called manubrium-limited ministernotomy, divides only the manubrium from the sternal notch to 1 cm below the manubrio-sternal junction. More than one third of patients undergoing conventional sternotomy develop clinically significant bleeding requiring post-operative red blood cell transfusion. Case series data suggest a potentially clinically significant difference in red blood cell transfusion requirements between the two techniques. Given the implications for National Health Service resources and patient outcomes, a definitive trial is needed. METHODS/DESIGN: This is a single-centre, single-blind, randomised controlled trial comparing aortic valve replacement surgery using manubrium-limited ministernotomy (intervention) and conventional median sternotomy (usual care). Two hundred and seventy patients will be randomised in a 1:1 ratio between the intervention and control arms, stratified by baseline logistic EuroSCORE and haemoglobin value. Patients will be followed for 12 weeks from discharge following their index operation. The primary outcome is the proportion of patients who receive a red blood cell transfusion post-operatively within 7 days of surgery. Secondary outcomes include red blood cell and blood product transfusions, blood loss, re-operation rates, sternal wound pain, quality of life, markers of inflammatory response, hospital discharge, health care utilisation, cost and cost effectiveness and adverse events. DISCUSSION: This is the first trial to examine aortic valve replacement via manubrium-limited ministernotomy versus conventional sternotomy when comparing red blood cell transfusion rates following surgery. Surgical trials present significant challenges; strengths of this trial include a rigorous research design, standardised surgery performed by experienced consultant cardiothoracic surgeons, an agreed anaesthetic regimen, patient blinding and consultant-led patient recruitment. The MAVRIC trial will demonstrate that complex surgical trials can be delivered to exemplary standards and provide the community with the knowledge required to inform future care for patients requiring aortic valve replacement surgery. TRIAL REGISTRATION: International Standard Randomised Controlled Trial Number (ISRCTN) ISRCTN29567910. Registered on 3 February 2014. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s13063-016-1768-4) contains supplementary material, which is available to authorized users. BioMed Central 2017-01-28 /pmc/articles/PMC5273792/ /pubmed/28129780 http://dx.doi.org/10.1186/s13063-016-1768-4 Text en © The Author(s). 2017 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Study Protocol Akowuah, Enoch Goodwin, Andrew T. Owens, W. Andrew Hancock, Helen C. Maier, Rebecca Kasim, Adetayo Mellor, Adrian Khan, Khalid Murphy, Gavin Mason, James Manubrium-limited ministernotomy versus conventional sternotomy for aortic valve replacement (MAVRIC): study protocol for a randomised controlled trial |
title | Manubrium-limited ministernotomy versus conventional sternotomy for aortic valve replacement (MAVRIC): study protocol for a randomised controlled trial |
title_full | Manubrium-limited ministernotomy versus conventional sternotomy for aortic valve replacement (MAVRIC): study protocol for a randomised controlled trial |
title_fullStr | Manubrium-limited ministernotomy versus conventional sternotomy for aortic valve replacement (MAVRIC): study protocol for a randomised controlled trial |
title_full_unstemmed | Manubrium-limited ministernotomy versus conventional sternotomy for aortic valve replacement (MAVRIC): study protocol for a randomised controlled trial |
title_short | Manubrium-limited ministernotomy versus conventional sternotomy for aortic valve replacement (MAVRIC): study protocol for a randomised controlled trial |
title_sort | manubrium-limited ministernotomy versus conventional sternotomy for aortic valve replacement (mavric): study protocol for a randomised controlled trial |
topic | Study Protocol |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5273792/ https://www.ncbi.nlm.nih.gov/pubmed/28129780 http://dx.doi.org/10.1186/s13063-016-1768-4 |
work_keys_str_mv | AT akowuahenoch manubriumlimitedministernotomyversusconventionalsternotomyforaorticvalvereplacementmavricstudyprotocolforarandomisedcontrolledtrial AT goodwinandrewt manubriumlimitedministernotomyversusconventionalsternotomyforaorticvalvereplacementmavricstudyprotocolforarandomisedcontrolledtrial AT owenswandrew manubriumlimitedministernotomyversusconventionalsternotomyforaorticvalvereplacementmavricstudyprotocolforarandomisedcontrolledtrial AT hancockhelenc manubriumlimitedministernotomyversusconventionalsternotomyforaorticvalvereplacementmavricstudyprotocolforarandomisedcontrolledtrial AT maierrebecca manubriumlimitedministernotomyversusconventionalsternotomyforaorticvalvereplacementmavricstudyprotocolforarandomisedcontrolledtrial AT kasimadetayo manubriumlimitedministernotomyversusconventionalsternotomyforaorticvalvereplacementmavricstudyprotocolforarandomisedcontrolledtrial AT melloradrian manubriumlimitedministernotomyversusconventionalsternotomyforaorticvalvereplacementmavricstudyprotocolforarandomisedcontrolledtrial AT khankhalid manubriumlimitedministernotomyversusconventionalsternotomyforaorticvalvereplacementmavricstudyprotocolforarandomisedcontrolledtrial AT murphygavin manubriumlimitedministernotomyversusconventionalsternotomyforaorticvalvereplacementmavricstudyprotocolforarandomisedcontrolledtrial AT masonjames manubriumlimitedministernotomyversusconventionalsternotomyforaorticvalvereplacementmavricstudyprotocolforarandomisedcontrolledtrial |